Status: Recruiting
Prospective Multicenter Cohort Study to Validate Four Groups of Biomarkers for Assessing Lung Cancer Risk Among Patients With Atheromatous Cardiovascular Disease in a Screening Pathway
Interventional study with minimal risks and constraints, with evaluation of the incidence of lung cancers by low-dose thoracic CT scan without injection of contrast medium, of the immunological, inflammatory and metabolic blood profile and of the microbiota; systematic proposal of smoking cessation for active smokers or assistance in maintaining cessation.
Participants needed: 750
Trial details
Age: 45-80Biological sex: AllType: InterventionalSponsor: Assistance Publique Hopitaux De MarseilleUpdated: Apr 26, 2024Locations: 1
Eligibility criteria
1- All PREVALUNG or PREVALUNG ETOILE participants [+17]
cancer history < 5 years (except carcinoma in situ of the uterine cervix, basal... [+10]